Introduction
According to a recent report by Mordor Intelligence, the retail pharmacy market is projected to grow from around USD 0.83 trillion in 2025 to USD 1.29 trillion by 2030, registering a compound annual growth rate (CAGR) of approximately 9.2%. This forecast underscores strong and sustained momentum in the sector, driven by demographic shifts, broader services, and channel transformation. The surge in demand for prescription medications among aging populations, along with the increasing role of pharmacies as healthcare access points, is reshaping how patients interact with retail pharmacy providers.
Key Trends
Several major trends are shaping the trajectory of the retail pharmacy market, reflecting both foundational shifts in healthcare delivery and emerging consumer behavior.
Aging Population and Chronic Disease Burden
The rising prevalence of chronic conditions among older adults is pushing pharmacies to move beyond traditional dispensing. Pharmacists are increasingly offering clinical services such as vaccinations, point-of-care testing, and medication adherence support. This shift positions retail pharmacies as community health hubs, especially in regions where aging demographics drive sustained demand for prescription drugs.
Growth in Over-the-Counter (OTC) and Self-Care
Self-medication is rising globally, fueling demand for OTC products. Consumers are turning to pharmacies for quick access to self-care solutions, and regulatory changes are making it easier for more advanced therapies to move to OTC status. As a result, pharmacies are leveraging digital tools, symptom checkers, and click-and-collect models to capture this growing demand.
Omni-Channel and E-Commerce Penetration
The retail pharmacy market is increasingly adopting an omni-channel strategy: physical stores, online platforms, and hybrid models co-exist. Online pharmacies are growing rapidly, with same-day delivery, transparent pricing, and auto-refill services enhancing convenience. At the same time, traditional chains are integrating digital experiences to retain customer loyalty and compete with pure-play e-pharmacy platforms.
Expanded Pharmacist Role
In many markets, pharmacists’ scope of practice is broadening. They are being authorized to immunize, test for chronic diseases, and manage certain conditions. This regulatory flexibility is creating new revenue lines and turning pharmacies into frontline care providers. It is also helping them manage the margin pressures from tight reimbursement.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
https://www.mordorintelligence.com/ja/industry-reports/retail-pharmacy-market?utm_source=emailwire
Market Segmentation
In analyzing the retail pharmacy market, Mordor Intelligence outlines its segmentation across product types, pharmacy formats, and geography:
By Product Type (Value)
- Prescription Medicines
- Over-The-Counter (OTC) Medicines
- Health & Wellness / Personal Care Products
- Medical Devices & Supplies
By Pharmacy Format (Value)
- Chain Pharmacies
- Independent Pharmacies
- Supermarket / Hypermarket In-Store Pharmacies
- Online Pharmacies
By Geography
- North America
- South America
- Europe
- Middle east&Africa
- Asia pacific
Key Players
The competitive landscape of the retail pharmacy market is defined by both global chains and agile online platforms. Leading pharmacy chains benefit from dense networks, data analytics, and centralized operations. They invest heavily in automation, clinical services, and digital tools to retain customers and improve margins.
- Walgreens Boots Alliance
- CVS Health
- MedPlus
- Grupo Casa Saba
- Walvax Biotechnology
Mordor Intelligence highlights that major pharmacy chains are responding by building or enhancing central-fill facilities, deploying robotics, and negotiating long-term value-based contracts with payers. Pharmacists are increasingly part of care-delivery teams, especially in systems where regulation allows them to test, vaccinate, and counsel.
Conclusion
The retail pharmacy market is on a strong upward trajectory, with the forecasted growth to USD 1.29 trillion by 2030 reflecting fundamental shifts in healthcare delivery. Key drivers include the increasing prevalence of chronic illnesses among aging populations, an expanding role for pharmacists in patient care, and the rise of OTC and self-care products. Meanwhile, the blend of physical and digital channels is redefining how consumers access medications and services.
Despite margin pressures from vertical integration and competitive pricing, retail pharmacy operators are adapting investing in automation, new business models, and clinical services. The growth outlook remains compelling, and the market is poised for continued expansion, innovation, and relevance in global healthcare delivery.
Industry related Reports:
Europe Over-the-counter (OTC) Drugs Market: The European OTC Drugs Market is segmented by Product Type, including cough, cold and flu products, analgesics, and others; by Formulation, such as tablets, capsules, and additional formats; by Age Group, including pediatric (0–14 years) and other consumer segments; and by Sales Format, covering branded, generic, and private-label OTC products. The market is further categorized by Distribution Channel, including hospital pharmacies and other retail channels, as well as by Geography, spanning Germany, the United Kingdom, and additional European countries.
Loratadine Market: The Loratadine Market Report segments the industry by type including tablets, capsules, syrup, and other formulations along with distribution channels such as retail pharmacies and additional outlets. It further categorizes the market by end users (adults, pediatrics, and geriatrics) and by formulation type, covering single-ingredient loratadine and other combinations.
Asia-Pacific Over-the-counter (OTC) Drugs Market: The Asia-Pacific Over-The-Counter (OTC) Drugs Market Report covers segmentation by product type including cough, cold, and flu medicines, analgesics, dermatology OTC products, and more along with formulation types such as tablets and capsules, liquids and syrups, among others. It further analyzes the market by distribution channel, including hospital pharmacies, retail pharmacies, and drugstores, as well as by country, spanning China, Japan, India, and additional markets across the region.
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
